MEDICINOVA, INC. Peo Actually Paid Comp Amt
MEDICINOVA, INC. (MNOV) reported Peo Actually Paid Comp Amt of $1.34 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-29.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-04-29
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.34M DEF 14A · filed 2026-04-29 |
| 2024-12-31 | $1.61M DEF 14A · filed 2026-04-29 |
| 2023-12-31 | $1.15M DEF 14A · filed 2026-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |